[Restoration of the menstrual and generative functions in genital endometriosis after treatment with various types of synthetic progestins]

Non-randomised trial OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-13 ⓘ

Treatment with synthetic progestins restored menstrual function in 75.3 percent and childbearing in 22.6 percent of 353 patients with endometriosis, prompting recommendations for individualized dosing based on patient characteristics.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The results of therapeutic use of synthetic progestins (infecundin, bisecurin, Nonovion) in 353 patients with endometriosis are presented. Restoration of the menstrual function was achieved in 75.3 percent and of childbearing in 22.6 percent of the patients. An individual approach to the choice of a type and dose of synthetic progestins depending upon the patient's age, duration of the disease, type of endometriosis, and hormonal background is recommended.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Genital Neoplasms, Female Menstruation Progesterone Congeners Reproduction Adult Adult Drug Evaluation Drug Evaluation Drug Therapy, Combination Drug Therapy, Combination Endometriosis Endometriosis Female Female Follow-Up Studies Follow-Up Studies Genital Neoplasms, Female Genital Neoplasms, Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-06T06:14:58.568748+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:49.153990+00:00
License: CC0 · commercial use OK